Recent Price Trend in ADMA Biologics (ADMA) is Your Friend, Here's WhyZacks Investment Research • 03/20/24
Wall Street Analysts Think Adma Biologics (ADMA) Could Surge 33.56%: Read This Before Placing a BetZacks Investment Research • 03/18/24
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®GlobeNewsWire • 03/11/24
Adma Biologics (ADMA) Is Up 4.94% in One Week: What You Should KnowZacks Investment Research • 03/05/24
Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 28.36%: Here's is How to TradeZacks Investment Research • 03/01/24
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 02/28/24
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024GlobeNewsWire • 02/21/24
ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlyticsGlobeNewsWire • 02/21/24
Does Adma Biologics (ADMA) Have the Potential to Rally 31.55% as Wall Street Analysts Expect?Zacks Investment Research • 02/05/24
Wall Street Analysts Predict a 27.09% Upside in Adma Biologics (ADMA): Here's What You Should KnowZacks Investment Research • 01/19/24
ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business UpdateGlobeNewsWire • 01/08/24
Are You Looking for a Top Momentum Pick? Why Adma Biologics (ADMA) is a Great ChoiceZacks Investment Research • 01/05/24
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares ManagementGlobeNewsWire • 12/18/23
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and OlderGlobeNewsWire • 12/12/23